Ayala Pharmaceuticals Inc (ADXS)

[investisbest]

I actually think the root cause for many folks misunderstanding of timing has to do with the way the market views immunotherapy as a whole. In other words, it's not "mainstream" which means platforms have to demonstrate conclusive evidence and likely jump through all the "phase hoops" through to FDA approval BEFORE entities start to bite.

From the outside, without really understanding the tech, anybody would have a perception that this is "This is too good to be true. Prove it."

The thing will Advaxis that is a potentially beautiful scenario for investors is that once the reality (really) sets in - there's going to be a "holy shite" moment or moments. And from there, irrational exuberance will take over. When Advaxis gets to that point, don't be surprised to see exponential gains in valuation - i.e. the kind folks saw in the .com days. That's why I believe market cap in the 10's of billions is possible if DOC and co. don't sell out early.

And of course, all of my prognosis completely assumes that the platform is really delivering a game-changing, near-cure across multiple types of constructs. Case and point, going 8/8 on that recent throat cancer group (http://www.fios1news.com/longisland/immunotherapy-tesed-at-mt-sinai-hospital-april-14-2017#.WPuV34jyuUn) seems almost unbelievable.

So, yes, we still need to be patient, but we are getting close - very close to seeing material change. And, I must iterate that although I believe the potential is there for 10's Bs in MC, DOC and co will likely sell earlier. Hopefully it will be high single-digit Bs or low teen Bs. Anything under 10 billion is robbery IMO.